emselex 7.5mg modified-release tablets
merus labs luxco s.a r.l. - darifenacin hydrobromide - modified-release tablet - 7.5mg
emselex 15mg modified-release tablets
merus labs luxco s.a r.l. - darifenacin hydrobromide - modified-release tablet - 15mg
enablex 7.5mg prolonged-release tablets
aspen medical products malaysia sdn bhd - darifenacin hydrobromide -
enablex 15mg prolonged-release tablets
aspen medical products malaysia sdn bhd - darifenacin hydrobromide -
emselex 7.5 mg tabletas de liberación prolongada
aspen labs s.a. de c.v. - darifenacina (bromhidrato) - darifenacina (bromhidrato)....7.5mg
darifenacin aristo 7,5 mg retardtabletten
enablex
pharmacy retailing (nz) ltd t/a healthcare logistics - darifenacin hydrobromide 17.85mg equivalent to darifenacin 15 mg; - modified release tablet - 15 mg - active: darifenacin hydrobromide 17.85mg equivalent to darifenacin 15 mg excipient: calcium hydrogen phosphate hypromellose magnesium stearate opadry red 00f15613 opadry white 00f18296 opadry yellow 00f12951 purified water - enablex is indicated for the treatment of overactive bladder. symptoms of overactive bladder include urgency, urge urinary incontinence and frequency.
enablex
pharmacy retailing (nz) ltd t/a healthcare logistics - darifenacin hydrobromide 8.929mg equivalent to darifenacin 7.5 mg; - modified release tablet - 7.5 mg - active: darifenacin hydrobromide 8.929mg equivalent to darifenacin 7.5 mg excipient: calcium hydrogen phosphate hypromellose magnesium stearate opadry white 00f18296 purified water - enablex is indicated for the treatment of overactive bladder. symptoms of overactive bladder include urgency, urge urinary incontinence and frequency.
enablex
aspen pharmacare australia pty ltd - darifenacin hydrobromide -
enablex 7.5 mg
novartis south africa (pty) ltd - darifenacin hydrobromide - tablet - each tablet contains darifenacin hydrobromide equiv. to darifenacin 7,5 mg